The Zacks Analyst Blog Highlights Roche, Fomento Economico Mexicano, Advanced Micro Devices, Union Pacific and Mondelez International

About this update from Fomento Economico Mexicano Sab De Cv Units Cons. Of 5 Shsb

For Immediate ReleaseChicago, IL – July 19, 2023 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Roche RHHBY, Fomento Económico Mexicano, FMX, Advanced Micro Devices AMD, Union Pacific Corp. UNP and Mondelez International, Inc. MDLZ.Here are highlights from Tuesday’s Analyst Blog:Q2 Earnings Scorecard and Analyst Reports for Roche, AMD and OthersThe Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features a real-time update on the Q2 earnings season and new research reports on 16 major stocks, including Roche, Fomento Económico Mexicano and Advanced Micro Devices. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Q2 Earnings Season ScorecardIncluding this morning's reports from Bank of America, Morgan Stanely and others, we now have Q2 results from 38 S&P 500 members. Total earnings for these 38 index members are up +5.6% from the same period last year on +8.3% higher revenues, with 86.8% beating EPS estimates and 68.4% beating revenue estimates.This is better than expected performance for this group of 38 S&P 500 members, with the EPS beats percentage of 86.8% the highest for this group in the last 20 quarters. This is notable as unlike many other recent quarters estimates for Q2 hadn't dropped that much.Looking at Q2 as a whole, S&P 500 earnings are expected to decline -9.4% from the same period last year on -0.5% lower revenues.A big part of the declines are due to the Energy sector whose Q2 earnings and revenues are expected to decline -48.8% and -27.8%, respectively. Excluding the Energy sector drag, Q2 earnings for the rest of the index would be down only -3.5% on +3% higher revenues.While index earnings are currently expected to modestly decline in 2023 Q3 as well, the growth pace would be positive had it not been for the Energy sector drag.Today's Featured Analyst Reports Shares of Roche Holding have modestly outperformed the Zacks Large Cap Pharmaceuticals industry over the year-to-date period (+1.6% vs. +0.2%). Company’s new drugs, namely Ocrevus, Hemlibra, Evrysdi and Tecentriq, recorded growth a...

View stock analysis, news, and events for Fomento Economico Mexicano Sab De Cv Units Cons. Of 5 Shsb